Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Intermittent claudication
by Most Market Reports in the Canada in 2021

The Intermittent claudication top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Market Reports Intermittent claudication Key Players in the Canada. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Intermittent claudication (Latin: claudicatio intermittens), is a symptom that describes muscle pain on mild exertion (ache, cramp, numbness or sense of fatigue), classically in the calf muscle, which occurs during exercise, such as walking, and is relieved by a short period of rest. It is classically associated with early-stage peripheral artery disease, and can progress to critical limb ischemia unless treated or risk factors are modified.
#
Company Name
Region
Tech Topics
Total
1
Knight Therapeutics, Inc.
Medicine,Health care,Biotechnology,
...[+2]
market report: 1
2
Cipher Pharmaceuticals, Inc.
Medicine,Health care,Core competency,
...[+2]
market report: 1
3
Covalon Technologies Ltd.
Medical equipment,Health care,Biotechnology,
...[+2]
market report: 1
4
Neovasc, Inc.
Tissue Processing,Heart valve,Computer hardware,
...[+2]
market report: 1
5
Apotex, Inc.
Manufacturing organization,Emergency medicine,Medicine,
...[+2]
market report: 1
6
SQI Diagnostics, Inc.
Medicine,Microarray,Sample Type,
...[+2]
market report: 1
7
Resverlogix Corp.
Pharmacy and Therapeutics,Clinical trial,Intermediation,
...[+2]
market report: 1
8
Aralez Pharmaceuticals, Inc.
Medicine,Cardiovascular agent,Clinical trial,
...[+2]
market report: 1
9
Hemostemix, Inc.
Clinical trial,Pharmacy and Therapeutics,Cell therapy,
...[+2]
market report: 1
10
DalCor Pharmaceuticals Canada, Inc.
Dalcetrapib,Medicine,Health care,
...[+2]
market report: 1
11
Novoheart Holdings, Inc.
Cardiovascular agent,Drug discovery,Toxicity,
...[+1]
market report: 1
12
La Jolla Capital, Inc.
Mineral exploration,Precious metal,Mining engineering,
...[+2]
market report: 1
13
Merus Labs International, Inc.
Over-the-counter,Medicine,Adenomyosis,
...[+2]
market report: 1
14
Conavi Medical, Inc.
Medical equipment,Health care,Medical imaging,
...[+2]
market report: 1
15
Amorchem
Venture capital,Exit strategy,Biomedicine,
...[+2]
market report: 1
16
Mespere LifeSciences, Inc.
Medical equipment,Health care,Continuous monitoring,
...[+2]
market report: 1
17
SciCann Therapeutics, Inc.
Endocannabinoid system,Health care,Biomedicine,
...[+2]
market report: 1
18
Cyclenium Pharma, Inc.
Biotechnology,Drug discovery,Drug marketing,
...[+2]
market report: 1
19
Toronto Innovation Acceleration Partners
Property management,Venture capital,Intellectual property,
...[+2]
market report: 1
20
Topstone Research
Biopharmaceutical,Quality assurance,Project management,
...[+2]
market report: 1
Page generation time: Jul 22 2025